The influence of cyclosporine a treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients
Van der Heyden, A.A.; van Oers, M.H.; Cornelissen, P.; Yong, S.L.; Wilmink, J.M.; Schellekens, P.T.
Transplantation Proceedings 20(2 Suppl 2: 190-195
1988
ISSN/ISBN: 0041-1345 PMID: 3284066 Document Number: 316018
Document emailed within 1 workday
Related Documents
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Yoshimura, N.; Kahan, B.D.; Oka, T. 1991: The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 958-960
Yagisawa, T.; Takahashi, K.; Teraoka, S.; Toma, H.; Agishi, T.; Ota, K. 1987: Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats Transplantation Proceedings 19(1 Part 2): 1801-1803
Takahashi, K.; Yagisawa, T.; Teraoka, S.; Tanabe, K.; Ebihara, K.; Fuchinoue, S.; Honda, H.; Toma, T.; Agishi, T.; Ota, K. 1989: Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center Transplantation Proceedings 21(1 Pt 2): 1563-1566
Ingsathit, A.; Sumethkul, V.; Chalermsanyakorn, P.; Jirasiritham, S. 2006: Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study Journal of the Medical Association of Thailand 89(Suppl 2): S235-S241
Hricik, D.E.; Bartucci, M.R.; Moir, E.J.; Mayes, J.T.; Schulak, J.A. 1991: Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 1007-1008
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Tredger, J.M.; Steward, C.M.; Williams, R. 1988: Blood cyclosporine concentrations in liver transplant recipients: assay method and influence of changed hepatic and renal function Transplantation Proceedings 20(3 Suppl 3: 391-393
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Trull, A.; Hue, K.; Tan, K.; Gore, S.; Whitewood, S.; Smyth, R.; Scott, J.; Price, C.; Wallwork, J. 1990: Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients Clinical Chemistry 36(8 Part 1): 1474-1478
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Stock, P.G.; Lantz, M.; Light, S.; Vincenti, F. 1996: In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients Transplantation Proceedings 28(2): 915-916
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Lang, P.; Buisson, C.; Rostoker, G.; Ben Maadi, A.; Fruchaud, G.; Deforge, L.; Chopin, D.; Abbou, C.; Romano, P.; Fleury, J. 1989: DHPG treatment of kidney transplant recipients with severe CMV infection Transplantation Proceedings 21(1 Part 2): 2084-2086
Sumrani, N.; Delaney, V.; Ding, Z.; Davis, R.; Butt, K.; Hong, J. 1991: Is cyclosporine indicated in HLA-identical renal transplant recipients? Transplantation Proceedings 23(1 Part 2): 1239-1240
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873